Aspen Aerogels, Inc. (ASPN)
| Market Cap | 463.91M -27.4% |
| Revenue (ttm) | 202.09M -49.1% |
| Net Income | -126.20M |
| EPS | -1.53 |
| Shares Out | 82.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 325,973 |
| Open | 5.53 |
| Previous Close | 5.87 |
| Day's Range | 5.53 - 5.76 |
| 52-Week Range | 2.30 - 9.35 |
| Beta | 3.06 |
| Analysts | Buy |
| Price Target | 7.75 (+38.64%) |
| Est. Earnings | Nov 5, 2026 |
About ASPN
Aspen Aerogels, Inc., an aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America. It operates through two segments: Thermal Barrier and Energy Industrial. The company offers PyroThin aerogel thermal barriers for use in battery packs in EVs; Pyrogel XTE for refineries and petrochemical facilities; Pyrogel HPS for high temperatures and in dema... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for ASPN stock is "Buy." The 12-month stock price target is $7.75, which is an increase of 38.64% from the latest price.
News
Aspen Aerogels management to meet with B. Riley
Meeting to be held in New York on September 24 hosted by B. Riley.
Aspen Aerogels Slides: Investor presentation
Aspen Aerogels has posted slides in relation to its latest quarterly earnings report, which was published on September 15, 2026.
Aspen Aerogels management to meet virtually with Craig-Hallum
Virtual Meeting to be held on September 22 hosted by Craig-Hallum.
Aspen Aerogels Transcript: Oppenheimer 29th Annual Technology, Internet & Communications Conference
EV and Energy Industrial markets are stabilizing and poised for growth, with European Thermal Barrier revenue outlook raised due to broad OEM wins and a key Jaguar Land Rover award. Operational resilience, cost controls, and a dual supply strategy support strong incremental margins and sustainable expansion.
Aspen Aerogels price target raised to $5 from $4 at Barclays
Barclays analyst J. David Anderson raised the firm’s price target on Aspen Aerogels (ASPN) to $5 from $4 and keeps an Underweight rating on the shares. The company reported a…
Aspen Aerogels price target raised to $9 from $7 at B. Riley
B. Riley analyst Ryan Pfingst raised the firm’s price target on Aspen Aerogels (ASPN) to $9 from $7 and keeps a Buy rating on the shares. The firm sees improved…
Aspen Aerogels price target raised to $7.75 from $5.75 at Roth Capital
Roth Capital analyst Chip Moore raised the firm’s price target on Aspen Aerogels (ASPN) to $7.75 from $5.75 and keeps a Buy rating on the shares.
Aspen Aerogels Earnings Call Transcript: Q2 2026
Q2 2026 revenue rose 32% sequentially to $49.8 million, led by strong thermal barrier sales and deferred GM revenue. Energy industrial targets 20% growth in 2026, with LNG and subsea projects driving Q3 guidance of $65–$80 million revenue and $7–$15 million adjusted EBITDA. European thermal barrier outlook was raised, and the East Providence plant is on track for full recovery in H1 2027.
Aspen Aerogels Earnings release: Q2 2026
Aspen Aerogels released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Aspen Aerogels Slides: Q2 2026
Aspen Aerogels has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Aspen Aerogels Quarterly report: Q2 2026
Aspen Aerogels has published its Q2 2026 quarterly earnings report on August 6, 2026.
Aspen Aerogels reports Q2 adjusted EPS (22c), consensus (20c)
Reports Q2 revenue $49.8M, consensus $42.42M. “Q2 quarter demonstrated the resilience of our team and the durability of our business. As we managed through the East Providence incident, we kept…
Aspen Aerogels sees Q3 EPS (11c)-(7c), consensus (13c)
Sees Q3 revenue $65M-$80M, consensus $56.93M.
Aspen Aerogels sees FY26 CapEx less than $10M
06:52 EDT Aspen Aerogels (ASPN) sees FY26 CapEx less than $10M
Aspen Aerogels, Inc. Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Q2 2026 Thermal Barrier revenue of $29.5 million, up 81% quarter-over-quarter Q3 2026 expected revenue range of $65 to $80 million and adjusted EBITDA range of $7 to $15 million European Thermal Barri...
Aspen Aerogels, Inc. to Present at the 29th Annual Oppenheimer Conference
NORTHBOROUGH, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in sustainability and electrification solutions, today announce...
Aspen Aerogels, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call
NORTHBOROUGH, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Grant Thoel...
Aspen Aerogels Named a 2025 Supplier of the Year by General Motors
NORTHBOROUGH, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”), a technology leader in aerogel-based sustainability and electrification solutions, ...
Aspen Aerogels initiates staged restart of East Providence facility
Aspen Aerogels (ASPN) announced the successful initiation of a staged restart of its manufacturing operations at its East Providence, Rhode Island facility. The restart began after mechanical, operati...
Aspen Aerogels Begins Staged Restart of East Providence Facility
NORTHBOROUGH, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced the successful initiation of a staged restart of its manufacturing op...
Aspen Aerogels Transcript: AGM 2026
The meeting covered director elections, auditor ratification, and several advisory votes, all of which passed. No questions were raised by stockholders, and final voting results will be filed with the SEC.
Aspen Aerogels price target raised to $4 from $3 at Barclays
Barclays analyst J. David Anderson raised the firm’s price target on Aspen Aerogels (ASPN) to $4 from $3 and keeps an Underweight rating on the shares. The company reported “modestly…
Aspen Aerogels price target raised to $5.75 from $3 at Roth Capital
Roth Capital raised the firm’s price target on Aspen Aerogels (ASPN) to $5.75 from $3 and keeps a Buy rating on the shares after its Q1 results. While near-term visibility…
Aspen Aerogels reports Q1 adjusted EPS (28c), consensus (26c)
Reports Q1 revenue $37.9M, consensus $36.66M. “We are immensely grateful that no employees were seriously injured in the incident. We are also appreciative of the professional work of first responders...
Aspen Aerogels sees Q2 EPS (24c)-(17c), consensus (21c)
Sees Q2 revenue $40M-$48M, consensus $41.08M.